|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:1172-1179
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From the Department of Cardiac Surgery, Children's Hospital, and the Department of Surgery, Harvard Medical School,a and the Departments of Pathologyb and Neurology,c Children's Hospital and Harvard Medical School, Boston, Mass.
Supported by a Habilitandenstipendium of the Deutsche Forschungsgemeinschaft NO344/1-1 (G.N.). The S-100 enzyme kit was kindly provided by Sangtec Medical AB, Bromma, Sweden. The NIRO 500 system was provided by Hamamatsu Photonics KK, Hamamatsu City, Japan.
Received for publication Aug 28, 1998. Revisions requested Oct 30, 1998. Revisions received Feb 2, 1999. Accepted for publication Feb 19, 1999. Address for reprints: Richard A. Jonas, MD, Department of Cardiac Surgery, Children's Hospital, 300 Longwood Ave, Boston, MA 02115.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated for the National Society for Medical Research and the "Guide for the Care and the Use of Laboratory Animals" prepared by the National Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 86-23, revised 1985).
CPB technique
In all animals the CPB circuit consisted of a roller pump (Cardiovascular Instrument Corp, Wakefield, Mass), membrane oxygenator (VPCML plus; COBE Cardiovascular, Inc, Arvada, Colo), and sterile tubing (OLSON Medical Sales Inc, Ashland, Mass) with 40-µm arterial filter (pediatric extracorporeal blood filter; Pall Biomedical, Inc, Fajardo, PR). Pump prime and flow rates and alpha-stat strategy were as for phase I. After 30 minutes of cooling all animals underwent 120 minutes of deep hypothermia and circulatory arrest after which 0.25 mg/kg furosemide, 0.5 g/kg mannitol, and 10 mL sodium bicarbonate were administered into the pump. The animal was then rewarmed to a temperature of 37°C during 40 minutes. The heart was defibrillated as necessary at 25°C. Fresh whole blood from a donor animal was transfused into the pump as required to increase the hematocrit to a range of 20% to 25% during rewarming. Ventilation was restarted 10 minutes before the weaning from CPB, with an inspired oxygen fraction of 0.4 (normoxia group) or 1.0 (hyperoxia group). The animal was then weaned from CPB. Intravenous protamine (6 mg/kg) was administered, followed by decannulation once the animal's hemodynamic condition was stable. If deemed necessary, dopamine was administered intravenously to facilitate weaning. After the operation all animals remained fully sedated, paralyzed, and intubated and were monitored continuously for 6 hours from the start of reperfusion after CPB, at which time the chest was opened by median sternotomy to allow perfusion fixation of the brain.
Data collection
Near-infrared spectroscopy. Before the operation a pair of fiberoptic optodes for near-infrared spectroscopy (NIRS) was attached to the head of the animal. The optode spacing was 3.0 to 3.5 cm in a coronal plane. The 2 optodes, a transmitter and a receiver of laser light at near-infrared wavelengths, were connected to a near-infrared spectrometer (NIRO-500; Hamamatsu Photonics KK, Hamamatsu City, Japan), which calculated relative concentration changes in oxyhemoglobin, deoxygenated hemoglobin, and oxidized cytochrome a,a3 in brain tissue. Data were recorded every 10 seconds throughout the experiment. A steep and sudden decrease of oxyhemoglobin, hemoglobin, and cytochrome a,a3 concentrations after the start of brain perfusion validated the accurate placement of the optodes in all experiments. A differential path length factor of 3.85 was assumed for the calculation of absolute chromophore changes.
1
Blood gases and biochemical analyses. Arterial and venous (jugular bulb) blood gas values, including electrolyte, glucose, and lactate concentrations, were measured at baseline, 5 minutes after the start of CPB, every 10 minutes during CPB, 30 minutes after the end of CPB, and at the end of the experiment (Nova 900; Nova Biomedical, Waltham, Mass). Additional blood samples were taken at baseline, 30 minutes after termination of CPB, and at the end of the experiment to determine concentrations of products of lipid peroxidation and nitric oxide production. Concentrations of enzyme markers of ischemic brain damage, neuron-specific enolase and S-100, were assessed at baseline and at the end of the experiment. The blood samples were immediately centrifuged and the serum was stored at 80°C for further processing. Glutamic oxaloacetate transaminase, glutamic pyruvic transaminase, lactate dehydrogenase, and creatine kinase were measured at the end of the experiment by standard laboratory kits and compared among groups.
Products of lipid peroxidation (malonaldehyde and 4-hydroxy-2[E]-nonenal;) were measured with a specific colorimetric assay kit (Lipid Peroxidation Kit; CN Biosciences, Inc, San Diego, Calif). Absorbance at 586 nm was determined with a standard spectrophotometer. Interference of heparin with the results was ruled out by control measurements.
2
As a measure of nitric oxide production, concentrations of the nitric oxide metabolites nitrite and nitrate were determined. The blood samples were centrifuged for 3 hours at 2000 rpm with a 10-µm filter (Centricon 10; Amicon Inc, Beverly, Mass). Nitrate was transformed to nitrite by 3 hours of incubation with nitrate reductase (Cayman's Nitrate/Nitrite Assay Kit; Alexis Corporation, San Diego, Calif). After the addition of Griess reagent, absorbance at 550 nm was measured with a standard 96-well plate reader.
3
Concentration of S-100 was measured by a luminescence immunoassay (Sangtec 100; Sangtec Medical AB, Bromma, Sweden), which determines the S100 B-subunit specific for brain damage at a detection limit of 0.02 mg/L. The emitted light was detected by a luminometer (Lumat LB 9501; Berthold Systems, Inc, Aliquippa, Pa).
4
Neuron-specific enolase was assayed by an enzyme immunoassay (Cobas Core NSE EIA; Roche Diagnostics Division, Basel, Switzerland) specific for the
subunit.
5
Histologic evaluations. The brain of the animal was fixed by perfusion with 4% paraformaldehyde 6 hours after reperfusion. Through a median sternotomy, a 12F cannula was introduced into the brachiocephalic trunk and 1 L of a balanced electrolyte solution (Normosol; Abbott Laboratories, Abbott Park, Ill) was infused through the cannula from a height of 1.5 m, followed by 4 L of 4% paraformaldehyde. The superior vena cava was opened to vent the effluent. The animal was then decapitated and the head was submerged in 10% formalin for an additional 24 hours, after which the brain was removed and submerged in 4% formaldehyde, typically for 2 weeks.
After fixation the brain was blocked into 8 to 10 coronal slabs that were embedded in paraffin, and 7-µm sections were stained with hematoxylin and eosin. Injury to the brain was histologically evaluated by a pathologist in a blinded fashion. Items on a standardized list of 24 of the major gray and white matter structures according to the nomenclature for porcine neuroanatomy, as previously described by Yoshikawa,
6 were examined; several of the most consistently damaged areas were grouped and scored cumulatively as 4 categories: the neocortex, the hippocampus, the caudate nucleus, and the cerebellum. As in previous studies,
7 neuropathologic damage was evaluated primarily by the presence of hypereosinophilic shrunken neurons with karyorrhectic nuclei suggestive of recent hypoxic-ischemic injury. Histologic changes were rated on an arbitrary scale: 0, represented no damage, 1 represented isolated damaged neurons, 2, represented small clusters of damaged neurons, 3 represented large clusters of injured neurons, 4 represented completely damaged neurons, and 5 represented frank cavitated lesions with necrosis.
Statistical analysis
All results were expressed as mean ± SEM. The operation was divided into 5 phases: baseline, cooling, deep hypothermia and circulatory arrest, rewarming, and reperfusion. To calculate differences between groups within a phase the repeated measures function was used. The Mann-Whitney U test was used for the analysis of the histologic score. Statistical analyses were facilitated by SPSS statistical software (version 7.0 for Windows; SPSS Inc, Chicago, Ill).
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Ihnken and associates
8 have emphasized the important role of oxygen free radicals in exacerbating myocardial injury during reperfusion after ischemia. They reported higher lipid oxygenation, increased nitric oxide formation, and worse cardiac contractility with hyperoxic management of CPB after hypoxia and ischemia-reperfusion of immature canine hearts than with normoxic management.
8 Furthermore, recent clinical studies comparing hyperoxic and normoxic management of CPB in cyanotic children also revealed higher damage from oxygen free radicals, as assessed by products of lipid peroxidation, after reperfusion.
9,10 These data have led many pediatric cardiac surgery centers to change from hyperoxic to normoxic management of CPB.
Increased lipid peroxidation, a marker of free oxygen radical damage, was indeed observed in our study, with higher oxygenation during CPB tending to increase these products as would be anticipated. However, oxygen free radicals are only one of several possible causes of neurologic damage, and their detrimental effects in the hyperoxia group were outweighed by other factors.
In keeping with other studies,
11 nitric oxide production decreased until the animals were killed 6 hours after deep hypothermia and circulatory arrest in this study. However, there were no differences between groups. A decrease in nitric oxide could play a role in the pathogenesis of brain injury by causing impairment of cerebral perfusion and metabolism,
12 but our results indicate that the observed differences in brain injury are unlikely to be due to differences in nitric oxide metabolism.
Different areas of the brain are known to have different degrees of vulnerability to a global hypoxic-ischemic insult such as is imposed during deep hypothermia and circulatory arrest. In rodent models the hippocampus (responsible for short-term memory) is usually most severely affected. The pattern of histologically demonstrated brain injury in this study was slightly different from that previously seen in our longer term survival studies of pigs that were killed on the fourth postoperative day after deep hypothermia and circulatory arrest.
13 The damage in this study was much more marked in the hippocampus. The differences between studies may be explained by the longer duration of ischemia (100 vs 120 minutes), phagocytosis of the damaged neurons during the longer survival interval, or regional variations in the time course of delayed neuronal injury.
It is interesting that our neuropathologist (who as in our previous studies was blinded to treatment assignment) was able to discern any damage at 6 hours after injury, because the neuropathologic literature suggests that injury is only detectable at the light microscopic level after 8 to 12 hours. Other than a greater degree of injury in the hippocampus, the pattern was for the most part similar to that seen previously after deep hypothermia and circulatory arrest in piglets but much less severe than would be expected after 120 minutes of circulatory arrest. It is probable that animals from both groups would have shown more severe damage had they been allowed to survive for 4 to 5 days because of both maturation of the histologic changes and ongoing delayed neuronal death.
Although we have speculated that the mechanism of improved outcome with hyperoxic perfusion is a simple improvement in intracellular brain oxygenation, there may be other causes for the differences in outcome between the normoxia and hyperoxia groups. Also, this study does not help to determine whether differences in PaO2 before CPB, during cooling, or during rewarming are of equal or indeed any importance. Previous studies of brain tissue PO2 have shown that hyperoxia at normothermia changes the average brain tissue PO2 only minimally.
14 Furthermore, hyperoxia has been shown to cause cerebral vasoconstriction
15 that leads to nonhomogeneous oxygen distribution.
16 Although the relative changes in the NIRS signals support the hypothesis that the improved outcome results from improved oxygen delivery, it is important to remember that the NIRS measurements taken in this study were relative and that there could have been important differences in baseline values. Although such differences cannot be excluded, they are most likely subtle because the redox status of cytochrome is believed to change only under severely hypoxic conditions
17 and the hemoglobin signal is derived mainly from venous blood in the brain.
18
Increasing arterial and venous PO 2 values during cooling were paralleled by a rising cerebral oxyhemoglobin signal and a decreasing cytochrome a,a3 signal, which we have seen in previous experimental and clinical studies.
13,19 Cytochrome a,a3and oxyhemoglobin concentrations tended to be higher during cooling and during deep hypothermia and circulatory arrest in the hyperoxia group, despite a presumed higher absolute baseline with respect to the normoxia group. Maximal decrease of the cytochrome a,a3 value during deep hypothermia and circulatory arrest has been shown to correlate with histologically demonstrated brain damage in previous studies from our laboratory.
20 Furthermore, cytochrome a,a3 values have been correlated with adenosine triphosphate levels of the brain during cardiac operations,
20 suggesting that the energy status of the brain starts to become depleted during cooling before deep hypothermia and circulatory arrest. The paradoxic finding of impaired brain oxygenation despite increasing PaO 2 may be explained by hemodilution and an increased affinity of oxygen for hemoglobin with the hypothermia and alkalosis that occur during alpha-stat management. Clinical data and a mathematical model indicate that oxygenation of the brain during deep hypothermia depends on the amount of physically dissolved oxygen.
21,22 A PaO2 within the reference range, such as was used in the normoxia group, may be insufficient to meet the oxygen demand of the brain during cooling.
During rewarming PO2 values in the jugular bulb were significantly lower in the normoxia group. Clinical studies have shown that severe desaturation in the jugular bulb during rewarming is associated with postoperative neuropsychologic deficits.
23
This study confirms a probable reduction in free radical injury with normoxic CPB management relative to hyperoxic CPB management. However, normoxic perfusion results in greater histologically demonstrated brain injury after a prolonged period of deep hypothermia and circulatory arrest. In view of the findings of phase I of this study that cerebral microemboli are not increased if a membrane oxygenator is used with an arterial filter and despite the limitations of current NIRS technology, the most likely mechanism of increased injury appears to be cerebral neuronal hypoxia. In our clinical practice we therefore currently use pure oxygen for all pediatric CPB.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
E. J. Hickey, X. You, V. Kaimaktchiev, and R. M. Ungerleider Hypoxemic reperfusion exacerbates the neurological injury sustained during neonatal deep hypothermic circulatory arrest: a model of cyanotic surgical repair Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 906 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dorotta, P. Kimball-Jones, and R. Applegate II Deep hypothermia and circulatory arrest in adults. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 66 - 76. [Abstract] [PDF] |
||||
![]() |
S. Schultz, D. Antoni, G. Shears, S. Markowitz, P. Pastuszko, W. Greeley, D. F. Wilson, and A. Pastuszko Brain oxygen and metabolism during circulatory arrest with intermittent brief periods of low-flow cardiopulmonary bypass in newborn piglets J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 839 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman Neurologic Monitoring on Cardiopulmonary Bypass: What Are We Obligated to Do? Ann. Thorac. Surg., June 1, 2006; 81(6): S2373 - S2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jungwirth, G. B. Mackensen, M. Blobner, F. Neff, B. Reichart, E. F. Kochs, and G. Nollert Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: Description of a new model J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 805 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zaitseva, G. Schears, S. Schultz, J. Creed, D. Antoni, D. F. Wilson, and A. Pastuszko Circulatory Arrest and Low-Flow Cardiopulmonary Bypass Alter CREB Phosphorylation in Piglet Brain Ann. Thorac. Surg., July 1, 2005; 80(1): 245 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Scallan Cerebral injury during paediatric heart surgery: perfusion issues Perfusion, July 1, 2004; 19(4): 221 - 228. [Abstract] [PDF] |
||||
![]() |
S. Schultz, J. Creed, G. Schears, T. Zaitseva, W. Greeley, D. F. Wilson, and A. Pastuszko Comparison of low-flow cardiopulmonary bypass and circulatory arrest on brain oxygen and metabolism Ann. Thorac. Surg., June 1, 2004; 77(6): 2138 - 2143. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Allen, M. Castella, G. D. Buckberg, and Z. Tan Conditioned blood reperfusion markedly enhances neurologic recovery after prolonged cerebral ischemia J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Allen, J. S. Veluz, G. D. Buckberg, E. Aeberhard, and L. J. Ignarro Deep hypothermic circulatory arrest and global reperfusion injury: Avoidance by making a pump prime reperfusate--A new concept J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Duebener, I. Hagino, T. Sakamoto, L. B. Mime, C. Stamm, D. Zurakowski, H.-J. Schafers, and R. A. Jonas Effects of pH Management During Deep Hypothermic Bypass on Cerebral Microcirculation: Alpha-Stat Versus pH-Stat Circulation, September 24, 2002; 106(12_suppl_1): I-103 - I-108. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Allen The reoxygenation injury: Is it clinically important? J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 16 - 19. [Full Text] [PDF] |
||||
![]() |
H. Abdul-Khaliq, R. Uhlig, W. Bottcher, P. Ewert, V. Alexi-Meskishvili, and P. E. Lange Factors influencing the change in cerebral hemodynamics in pediatric patients during and after corrective cardiac surgery of congenital heart diseases by means of full-flow cardiopulmonary bypass Perfusion, May 1, 2002; 17(3): 179 - 185. [Abstract] [PDF] |
||||
![]() |
K. S. Bandali, M. P. Belanger, and C. Wittnich Is hyperglycemia seen in children during cardiopulmonary bypass a result of hyperoxia? J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto Alternate explanation for the increasing oxygen consumption and lactatemia after surgery with hypothermic cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 816 - 817. [Full Text] [PDF] |
||||
![]() |
B. S Allen and M. N Ilbawi Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery Perfusion, January 1, 2001; 16(1_suppl): 19 - 29. [Abstract] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto Prevention of post-hypothermic circulatory arrest temporary neurologic deficits Ann. Thorac. Surg., November 1, 2000; 70(5): 1764 - 1765. [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto Alternate explanation of the ""delayed impairment of cerebral oxygenation"" Ann. Thorac. Surg., October 1, 2000; 70(4): 1447 - 1448. [Full Text] [PDF] |
||||
![]() |
R. A. Jonas Invited Commentary Ann. Thorac. Surg., September 1, 2000; 70(3): 755 - 755. [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto pH-stat strategies protect 60-minute central nervous system ischemia at 29.5{degrees}C Ann. Thorac. Surg., September 1, 2000; 70(3): 1001 - 1002. [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto Bohr effect during cooling to and rewarming from 20{degrees}C cannot be ignored Ann. Thorac. Surg., August 1, 2000; 70(2): 690 - 690. [Full Text] [PDF] |
||||
![]() |
T.-A. Miyamoto and K.-J. Miyamoto Monitoring adequacy of brain oxygenation Ann. Thorac. Surg., July 1, 2000; 70(1): 336 - 337. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J |